Bumetanide: Clinical Trials

7 trials of Bumetanide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 recruiting. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Active not recruiting 1, Recruiting 1
Phase 22Active not recruiting 1, Completed 1

Follow Bumetanide: new trials by email Literature Review of Bumetanide trials Research Report on Bumetanide

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects
NPT 2042 (bumetanide analog) or Matching Placebo - Epilepsy, Alzheimer Disease
Phase 1CompletedNeuroPro Therapeutics, Inc.502022-10-202023-04-04
Mechanisms of Diuretic Resistance in Heart Failure, Aim 1
Bumetanide Injection - Heart Failure
Phase 1RecruitingYale University752022-06-012026-05-22
Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells
Hepatic artery embolization (HAE), Bumetanide - Unresectable Hepatocellular Carcinoma
Phase 1 / Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center302017-04-052026-05-05
Diagnosing and Targeting Mechanisms of Diuretic Resistance in Heart Failure
Increased Intravenous Bolus Loop Diuretic Dose (Bumetanide or Furosemide), IV Chlorothiazide - Heart Failure
Phase 1CompletedYale University4582015-08-312025-08-17
NEMO1:NEonatal Seizure Using Medication Off-patent
Bumetanide - Neonatal Seizures
Phase 1 / Phase 2CompletedGreat Ormond Street Hospital for Children NHS Foundation Trust142011-08-012015-09-14
Pilot Study of Bumetanide for Newborn Seizures
Bumetanide, Normal Saline as Placebo - Seizures
Phase 1CompletedSoul, Janet , M.D.432010-01-012020-12-17
Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects
Bumetanide, Dapagliflozin - Type 2 Diabetes Mellitus
Phase 1CompletedAstraZeneca422009-07-012016-10-17

Conditions studied

Heart Failure (2)  ·  Hypoxia-Ischemia, Brain (2)  ·  Alzheimer Disease (1)  ·  Central Nervous System Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Drug Resistant Epilepsy (1)  ·  Epilepsy (1)  ·  Intracranial Hemorrhages (1)  ·  Seizures (1)

Sponsors

Yale University (2)  ·  AstraZeneca (1)  ·  Great Ormond Street Hospital for Children NHS Foundation Trust (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  NeuroPro Therapeutics, Inc. (1)  ·  Soul, Janet , M.D. (1)

Countries

United States (6)  ·  Ireland (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Hooman Yarmohammadi, MD (1)  ·  Janet Soul, MD,CM (1)  ·  Jeffrey Testani (1)  ·  Jeffrey Testani, MD (1)  ·  Ronit Pressler, Dr (1)

Results publications

PMID 25765333, PMID 29440005, PMID 36896716, PMID 40938670

NIH funding

R01DK130997 (1), R01HL128973 (1), R01NS066929 (1)